https://www.selleckchem.com/products/fr180204.html
Increases in fasting plasma glucose (PG) levels lead to a decrease in 2-deoxy-2-[ F]fluoro-D-glucose ([ F]FDG) uptake in the normal brain, especially in the precuneus, resulting in an Alzheimer's disease (AD)-like uptake pattern. Therefore, patients with higher PG levels, such as those with diabetes, can be erroneously diagnosed with AD when positron emission tomography (PET) imaging is done using [ F]FDG, due to reduced uptake of [ F]FDG in the precuneus. To help avoid an erroneous diagnosis of AD due to differences in glucose metabol
Like
Comment
Share
